Comera Life Sciences Holdings Inc (CMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,047 | -3,893 | -2,481 | -18,004 | -15,042 |
| Depreciation Amortization | 76 | 53 | 28 | 94 | 70 |
| Accounts receivable | 34 | -216 | 34 | -34 | -294 |
| Accounts payable and accrued liabilities | -246 | 487 | 126 | 863 | 1,020 |
| Other Working Capital | 414 | 457 | 272 | 2,552 | 1,557 |
| Other Operating Activity | 954 | 212 | 115 | 4,758 | 4,765 |
| Operating Cash Flow | $-4,813 | $-2,899 | $-1,906 | $-9,772 | $-7,924 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -94 | -94 | -88 | -29 | -29 |
| Investing Cash Flow | $-94 | $-94 | $-88 | $-29 | $-29 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,888 | 2,035 | 2,036 | N/A | 749 |
| Common Stock Issued | 1 | 1 | 0 | 1,490 | 661 |
| Other Financing Activity | -1,167 | -519 | -456 | 3,752 | 2,702 |
| Financing Cash Flow | $4,723 | $1,517 | $1,581 | $5,243 | $4,112 |
| Beginning Cash Position | 2,002 | 2,002 | 2,002 | 6,560 | 6,560 |
| End Cash Position | 1,818 | 526 | 1,589 | 2,002 | 2,719 |
| Net Cash Flow | $-184 | $-1,476 | $-414 | $-4,558 | $-3,841 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,813 | -2,899 | -1,906 | -9,772 | -7,924 |
| Capital Expenditure | -94 | -94 | -88 | -29 | -29 |
| Free Cash Flow | -4,907 | -2,993 | -1,994 | -9,800 | -7,953 |